Final height in patients with constitutional delay of growth and development from tall statured families

Otfrid Butenandt1, Susanne Bechtold, Annette Meidert

  • 1Dr. von Haunersches Kinderspital, University of Munich Auxologic Working Group, Munich, Germany. otfrid@butenandt.de

Insights

Constitutional delay of growth and development (CDGD) affects boys and girls equally, regardless of family height. Most children achieve normal final heights within their familial target range without intervention.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Constitutional delay of growth and development (CDGD) is a common cause of short stature in children.
  • It can occur in families of both short and tall stature.

Purpose of the Study:

  • To evaluate the final height outcomes in children with CDGD.
  • To determine if CDGD affects boys and girls differently.
  • To assess the necessity of therapeutic interventions for CDGD.

Main Methods:

  • Retrospective analysis of 33 patients (12 boys, 21 girls) diagnosed with CDGD.
  • Comparison of final achieved height with mean target height and familial target height range.

Main Results:

  • The mean target height for boys was 186.6 cm and for girls 173.6 cm; final heights were 191.2 cm and 176.9 cm, respectively.
  • 14 patients exceeded their mean target height by over 4 cm.
  • Nine patients exceeded their familial target height range; only one boy did not reach it.

Conclusions:

  • CDGD occurs equally in boys and girls, irrespective of familial height.
  • Children with CDGD typically achieve normal final heights within their familial target range.
  • Intervention is generally not required for CDGD.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
Heritability01:06

Heritability

Heritability is a statistical concept that measures the degree to which genetic differences among individuals contribute to trait variations within a population. It is a fundamental idea in genetics, often prone to misinterpretation. Heritability is expressed as a percentage, reflecting the proportion of variation in a specific trait across a population that can be linked to genetic differences. However, it's important to understand that heritability does not determine how "genetic" a trait is,...
Trihybrid Crosses02:27

Trihybrid Crosses

Trihybrid Crosses
Some of Mendel’s crosses examined three pairs of contrasting characteristics. Such a cross is called a trihybrid cross. A trihybrid cross is a combination of three individual monohybrid crosses. For example, plant height (tall vs. short), seed shape (round vs. wrinkled), and seed color (yellow vs. green).
The F1 generation plants of a trihybrid cross are heterozygous for all three traits and produce eight gametes. Upon self-fertilization, these gametes have an equal chance to...
Chi-square Analysis02:46

Chi-square Analysis

The chi-square test is a statistical hypothesis test. It is used to check whether there is a significant difference between an expected value and an observed value. In the context of genetics, it enables us to either accept or reject a hypothesis, based on how much the observed values deviate from the expected values.
The chi-square test was developed by Pearson in 1990.
The first step of performing a Chi-square analysis is to establish a null hypothesis, which assumes that there is no real...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...